Market revenue in 2023 | USD 437.7 million |
Market revenue in 2030 | USD 738.8 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell separation market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 62.85% in 2023. Horizon Databook has segmented the France cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Over the past decade, the number of biopharmaceutical companies in France increased significantly. French biopharmaceutical players such as Sanofi, Servier, Pierre Fabre, and Ipsen are focused on the development of novel therapies for cancer, hematological disorders, and cardiovascular diseases, among others.
In addition, France has world-class public & private scientific research institutions such as the French National Centre for Scientific Research, Institut Curie, Institut G. Roussy, and Pasteur Institute. The increasing number of research initiatives by these research organizations and companies is expected to significantly boost the demand for cell separation products for research purposes, thus creating a favorable environment for market growth.
The government of France adopted the EU Regulation 2017/745 on medical devices under the provisions covered by the French Public Health Code (FPHC). The National Agency for Safety of Medicines and Health Products (ANSM) is the competent authority for market surveillance of medical devices.
Horizon Databook provides a detailed overview of country-level data and insights on the France cell separation market , including forecasts for subscribers. This country databook contains high-level insights into France cell separation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account